Inflammatory Bowel Disease Drugs Market size was valued at USD 20.55 Billion in 2022 and is expected to reach USD 26.85 Billion By 2030 and grow at a CAGR of 3.4% over the forecast period of 2023-2030.  This burgeoning market is fueled by a confluence of factors, including: Escalating IBD prevalence: Approximately 10 million people worldwide suffer from IBD, primarily...